Longevity Peptides: Do They Actually Work? (2026)

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Not sure which peptide fits your goal? Take the 2-minute matcher →

Longevity & Mitochondrial Peptides (13)

Epitalon

A telomere-targeting peptide for longevity and cellular rejuvenation.

MOTS-C

A mitochondrial peptide that mimics exercise — boosts metabolism and endurance.

AICAR

An AMPK-activating research compound (acadesine) studied as an exercise mimetic for endurance and fat metabolism; reached cardiac-surgery trials, never approved, and WADA-banned in sport.

SS-31 (Elamipretide)

A mitochondrial peptide for cellular energy, anti-aging, and organ protection.

Humanin

A neuroprotective peptide for brain health and cognitive longevity.

NAD+

A cellular energy molecule for DNA repair, metabolism, and anti-aging.

FOXO4-DRI

A senolytic peptide that selectively eliminates damaged zombie cells for anti-aging.

Glutathione

The body's master antioxidant for cellular defense, immune support, detoxification, and skin health.

Methylene Blue

A synthetic phenothiazine dye and the first synthetic medicine; at low doses it acts as an alternative mitochondrial electron carrier, with FDA-approved medical uses and research interest in cognition — but a serious serotonin-syndrome interaction with serotonergic drugs.

Bronchogen

A Khavinson bronchial tetrapeptide (Ala-Glu-Asp-Leu / AEDL) studied in rat lung models for respiratory-tissue repair; preclinical, no human data.

Testagen

A Khavinson testis tetrapeptide (Lys-Glu-Asp-Gly / KEDG) marketed for reproductive-tissue support; contains no steroid and is unrelated to testosterone, with a verified sequence but no reproductive-outcome studies.

Prostamax

A Khavinson prostate tetrapeptide (Lys-Glu-Asp-Pro / KEDP); the synthetic peptide has minimal direct evidence, with prostate clinical data belonging to the Prostatilen extract.

Cardiogen

A Khavinson cardiac tetrapeptide (Ala-Glu-Asp-Arg / AEDR) studied in review and cell-transport work for a role in cardiovascular inflammaging; preclinical and mechanistic only, no human trials.

results

Cardiogen Results: What to Realistically Expect

There is no human timeline data for Cardiogen. What community sources report, why it's mostly theoretical, and how to read it honestly.

Testagen Results: Week-by-Week Timeline

Testagen has no human trials at all — so what shapes its reported timeline? Labeled community reports and the Russian short-course convention.

Prostamax Results: Week-by-Week Timeline

Prostamax has no human efficacy trial — so what drives the reported timeline? Preclinical chromatin data and labeled community reports, week by week.

Bronchogen Results: Week-by-Week Timeline

Bronchogen has no human efficacy trials — so what drives the reported timelines? Rat COPD-model data and labeled community reports, week by week.

AICAR Results Timeline: What Rodent Data Shows

AICAR has no human efficacy trials. So what does a results timeline rest on? Rodent endurance data and unverified community reports, unpacked.

Methylene Blue Results Timeline: What to Expect

The human memory study measured effects within hours of a single dose. What the data say about acute vs longer-term methylene blue use, week by week.

guides

Cardiogen Reconstitution: 20mg Mixing Chart

A 20mg Cardiogen vial plus 2mL bacteriostatic water gives 10mg/mL. Because community doses are tiny, dilution choice matters. Charts, storage, and steps.

Where to Buy Cardiogen: Price & Vendor Guide

Cardiogen sells as 20mg vials at roughly $2.50-$3.50/mg. With thin evidence, COA quality matters most. How to verify a vendor before you buy.

Where to Buy Testagen: Price & Vendor Guide

Testagen is a synthetic KEDG tetrapeptide — not testosterone, not a steroid. How to read a 447 Da COA, dodge the Testoluten mix-up, and what it costs.

SS-31 Reconstitution: 5mg + 2mL Chart

SS-31 degrades faster than most peptides if stored wrong. Step-by-step with dilution chart, syringe math, and 28-day storage rules.

Where to Buy SS-31: Price & Vendor Guide

Why a 50mg SS-31 vial costs less per mg than a 5mg — and how to spot the 639.8 Da signature on a real elamipretide COA.

SS-31 Bloodwork: 5 Labs to Track

Lactate and CoQ10 reveal mitochondrial changes before you feel them. 5 essential labs with optimal ranges and testing schedule.

dosing

Cardiogen Dosage: Community Protocols Explained

There is no trial-established Cardiogen dose. Community sources cluster around low-dose subcutaneous courses. The reconstitution math, explained.

Testagen Dosing: 10-20 Day Course Protocol

A synthetic testis tetrapeptide with no validated human dose — and no steroid. What research-chem sources report, plus the extract-vs-synthetic caveat.

Prostamax Dosing: 10-20 Day Course Protocol

A synthetic prostate tetrapeptide with no validated human dose. What research-chem sources report for short courses, plus the extract-vs-synthetic caveat.

Bronchogen Dosing: 10-20 Day Course Protocol

A synthetic bronchial tetrapeptide with no validated dose. What research-chem sources report for short courses, plus the extract-vs-synthetic caveat.

AICAR Dosing: No Validated Human Protocol

The only human AICAR dose on record is an IV cardiac protocol that failed. What mouse studies used, what forums claim, why neither translates.

Methylene Blue Dosing Guide: Low-Dose Ranges

More is not better with methylene blue — the dose-response is U-shaped. The low-dose ranges from clinical and community sources, and the MAO-A warning.

benefits

Cardiogen Benefits: What the Research Shows

Cardiogen is marketed for the heart, but its evidence is a handful of Russian cell studies. What the AEDR peptide research supports — and what it doesn't.

Testagen for Reproductive Support: The Evidence

Testagen is marketed for testis and reproductive support, but its one verified study isn't about reproduction at all. What the KEDG peptide research shows.

Prostamax for Prostate Health: The Extract Caveat

The prostate-health reputation behind Prostamax belongs to a tissue extract, not the synthetic KEDP peptide. What the research actually reported.

Bronchogen for Bronchial Repair: Rat COPD Data

Bronchogen's lung-repair reputation traces to rat COPD models and bronchial cell cultures — not human trials. What the research actually reported.

AICAR for Endurance: What the Mouse Data Shows

AICAR activates the same AMPK pathway as exercise — but the endurance and fat-loss evidence is almost entirely animal. Here's what research shows.

Methylene Blue Benefits: Memory & Mitochondria

A human fMRI study found low-dose methylene blue boosted memory retrieval. The mitochondrial mechanism, the cognition data, and where the hype outruns it.

articles

Peptides for Long COVID: What the Trials Show

BPC-157, MOTS-c and microdosed GLP-1s are marketed for Long COVID while semaglutide and tirzepatide trials run. What's studied, what isn't.

Peptide Bioregulators: The Khavinson Family

A clear-eyed map of the Khavinson bioregulators — what each synthetic peptide has real evidence for, and what actually belongs to the tissue extracts.

Best Peptides for Mitochondrial Health

6 mitochondrial peptides ranked by trial evidence — what each targets, who uses it, and what community sources actually report.

Nura Peptide Review: 25% Off Coupon

Nura Peptide: capsule peptides, pre-mixed nasal sprays, and a Reta+Cag combo. 25% off with thepeptidecatalog. Real pricing breakdown inside.

Ex-FDA Officials Push Back on RFK Peptide Reversal

Three former FDA officials say RFK Jr. mischaracterized their 2023 peptide-safety work. What the pushback means for buyers before the July 23 PCAC vote.

Best Peptides for Energy and Fatigue

Ranking of the peptides community sources describe for energy — what each one does, who it suits, and what users actually report.

side-effects

Testagen Side Effects: What the Evidence Shows

Despite the name, Testagen isn't testosterone — and its near-zero side-effect claim rests on almost no independent data. Here's the real picture.

Prostamax Side Effects: What the Evidence Shows

Its originators claim near-zero side effects, but independent safety data barely exists. What the research shows — and the risks it leaves out.

Bronchogen Side Effects: What the Evidence Shows

Its makers claim near-zero side effects, but independent respiratory safety data barely exists. What the rat studies show — and the risks left out.

AICAR Side Effects: What Human Trials Reported

The only human safety data comes from failed cardiac trials: uric-acid spikes, transient kidney effects, infusion-related low blood pressure.

Methylene Blue Side Effects: The Real Risks

The serotonin-syndrome interaction is the one that can be dangerous — plus G6PD, the high-dose reversal, and the harmless blue urine that scares people.

SS-31 Side Effects: Elamipretide Trial Data

Injection-site reactions lead. GI changes follow. Full safety breakdown from primary mitochondrial myopathy Phase 2/3 trials.

reconstitution

Testagen Reconstitution: 20mg Vial Mixing Chart

Testagen has no validated human concentration. See how community resources describe mixing the 20mg vial, plus syringe-unit math and storage limits.

Prostamax Reconstitution: 20mg Vial Mixing Chart

Prostamax has no validated human concentration. See how community resources describe mixing the 20mg vial, plus syringe-unit math and storage limits.

Bronchogen Reconstitution: 20mg Vial Mixing Chart

Bronchogen has no validated human concentration. See how community resources describe mixing the 20mg vial, plus syringe-unit math and storage rules.

AICAR Reconstitution: 50mg Vial Dilution Chart

AICAR has no validated human concentration. How community resources document 50mg-vial dilution math, syringe units, and 28-day storage.

NAD+ Reconstitution: 250mg + 2.5mL Chart

50mg = 50 units — NAD+ uses larger volumes than most peptides. Step-by-step with dilution chart, syringe math, and storage.

MOTS-c Reconstitution: 5mg & 10mg Dilution Chart

One syringe math mistake wastes a $60 vial. Dilution chart for both 5mg and 10mg vials, exact unit conversions, and 28-day storage rules.

buying-guide

Where to Buy Prostamax: Price & Vendor Guide

Prostamax is a synthetic KEDP tetrapeptide, not the Prostatilen prostate extract. How to read a 487 Da COA and spot the mix-up before you buy.

Where to Buy Bronchogen: Price & COA Guide

Bronchogen is a synthetic AEDL tetrapeptide, not a bronchial extract. How to read a 446 Da COA, avoid the mix-up, and what a vial really costs.

Where to Buy AICAR: Price & Vendor Guide

AICAR is a WADA-banned research chemical with no proven human benefit. What COA, purity, and identity checks actually matter before you buy.

Where to Buy Methylene Blue: Vendor Guide

Pharmaceutical-grade methylene blue costs a few dollars per mL — but aquarium-grade carries heavy metals. How two COA-tested vendors compare.

Where to Buy Glutathione: Form & Vendor Guide

Injectable, buccal, or liposomal -- the form you pick matters more than the vendor. Per-mg pricing, COA red flags, and what to avoid.

Where to Buy NAD+: Price & Vendor Guide

500mg vials vs IV bags, why sodium salt matters, and what a real NAD+ COA proves. Per-mg pricing, vendor picks, and dosing math inside.

comparison

AICAR vs MOTS-C: Two Paths to AMPK

AICAR and MOTS-C flip the same AMPK switch by two different routes. Both show promise in mice, neither is proven in humans. The mechanism split.

MOTS-C vs Metformin for Longevity: Key Differences

One is a 70-year-old diabetes drug, the other a mitochondrial peptide found in 2015. How MOTS-c and metformin compare on evidence, safety, and cost.

SLU-PP-332 vs MOTS-c: Two Exercise Mimetics

Synthetic ERR pan-agonist vs mitochondria-encoded AMPK activator. Same goal, opposite philosophies, and the stack rationale that ties them.

SS-31 vs MOTS-c: Mitochondrial Peptides

SS-31 stabilizes cardiolipin, MOTS-c activates AMPK — different targets, different results. Full comparison with dosing and research.

clinical

FDA Peptide Panel: Members Sell BPC-157, TB-500

AP investigation: FDA's peptide advisory panel includes clinicians who sell BPC-157 and TB-500 — what it means for the July 23 vote.

FDA Staff: No Compounding for BPC-157, TB-500, 5 More

FDA scientists recommend against adding BPC-157, TB-500, MOTS-c and 4 more to the compounding list before the July 23 vote. What it means for buyer access.

7 Peptides Go to FDA Vote July 23: What Buyers Need

FDA's compounding panel votes on BPC-157, TB-500, KPV, MOTS-c and 3 more July 23-24. What each outcome means for access — and where to buy now.

Price Comparisons

Compare Epitalon Prices

Find the best deals from trusted vendors

Compare SS-31 (Elamipretide) Prices

Compare MOTS-C Prices

Compare NAD+ Prices

Compare Methylene Blue Prices

Compare FOXO4-DRI Prices

Compare Glutathione Prices

Compare Bronchogen Prices

Compare AICAR Prices

Compare Testagen Prices

Compare Prostamax Prices

Compare Cardiogen Prices

Related Research Goals

Browse Other Categories

This page is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Key takeaways

Anti-aging & longevity peptides are short-chain amino acid sequences that modulate specific aging-related pathways. Growth hormone secretion, telomere maintenance, mitochondrial function, cellular senescence, and immune restoration. Through receptor binding and signal transduction rather than broad metabolic effects.
Epithalon activates telomerase and has demonstrated 33–45% increases in telomerase activity in human cell culture, correlating with extended replicative capacity and telomere length maintenance.
Growth hormone secretagogues like Ipamorelin and CJC-1295 restore youthful GH pulsatility without the supraphysiological dosing and side effect profile of exogenous growth hormone administration.
Mitochondrial-targeted peptides including MOTS-C and SS-31 address mitochondrial dysfunction. One of the nine hallmarks of aging. By activating AMPK, stabilizing cardiolipin, and reducing oxidative stress at the electron transport chain level.
FOXO4-DRI is the only peptide senolytic with published in vivo data showing functional rejuvenation in aged mammals through selective clearance of senescent cells that secrete inflammatory SASP factors.
Evidence quality varies: Thymosin Alpha-1 has decades of human clinical data and regulatory approval in multiple countries, while peptides like Epithalon rely primarily on animal models and small human cohorts without large-scale Western trials.
Real Peptides produces every anti-aging & longevity peptide through small-batch synthesis with exact amino acid sequencing and third-party purity verification to ensure consistent receptor binding affinity across research applications.

realpeptides.co

Research context

Read sources and limitations before applying a claim.

Safety considerations and what the research does not yet show

The enthusiasm around longevity peptides should be tempered with realistic assessment of what we know and do not know. While many compounds have promising preclinical and even clinical data, longevity specifically, measured as actual lifespan extension in humans, has not been demonstrated for any peptide. What we have are improvements in biomarkers and risk factors associated with aging, not proof that using these peptides will make humans live longer. This distinction matters. Improving telomere length is not the same as proving someone will live longer. Enhancing mitochondrial function is not the same as preventing age-related disease. The hallmarks of aging are correlated with lifespan, but correlation and causation are not identical. Interventions that modify these hallmarks may or may not translate to actual longevity benefits. The safety data, while generally reassuring for most peptides, is also incomplete. Long-term human studies are rare. Most peptides have been used clinically for specific indications, not for decades-long longevity protocols. Potential effects of very long-term use are unknown. The absence of documented problems is not the same as proof of safety. Specific concerns apply to specific peptides. For Epitalon and telomerase activators, there is theoretical concern about promoting cancer. Telomerase is active in most cancer cells, enabling their unlimited proliferation. Activating telomerase systemically could theoretically promote malignant transformation. However, no clinical evidence suggests Epitalon increases cancer risk, and some data suggests it may actually reduce tumor development. The concern remains theoretical. For growth hormone peptides, the relationship to cancer is also debated. IGF-1, which rises with growth hormone stimulation, is associated with increased cancer risk in epidemiological studies. However, these associations are with endogenously high IGF-1, not with peptide-stimulated increases. Whether peptide use affects cancer risk is unknown. Prudent researchers may avoid GH peptides if they have personal or family history of hormone-sensitive cancers. Many peptides remain unapproved by regulatory agencies. The FDA has flagged numerous peptide bulk substances as potential safety concerns in compounding, including BPC-157, LL-37, DSIP, Epitalon, injectable GHK-Cu, and thymosin beta-4 fragments. This does not necessarily mean these peptides are dangerous, but it does mean they lack the safety documentation that FDA approval would require. Quality and purity are significant concerns. Peptides from unverified sources may be contaminated, degraded, mislabeled, or counterfeit. Testing by independent laboratories is essential for researchers using peptides obtained outside regulated channels. Proper handling and reconstitution also affects peptide integrity. Interactions with medications are largely unstudied. Researchers taking prescription drugs should consider potential interactions, particularly for peptides affecting immune function, metabolic processes, or growth factor signaling. Medical supervision is advisable for complex protocols, especially in individuals with existing health conditions. The honest summary is that longevity peptides show genuine promise based on available evidence, but that evidence has limitations. Responsible use involves understanding both what the research shows and what it does not yet establish. Benefits are plausible but not guaranteed. Risks are generally low but not zero. Individual judgment and, ideally, medical guidance should inform decisions about peptide use for longevity purposes.

Source: seekpeptides.com ↗

Design notes for reproducible studies

1) Choose endpoints first (mitochondrial oxygen rate, sleep, tissue function). 2) Control light exposure, feeding schedule, temperature. 3) Use pulse or block timing to test cause and effect. 4) Track HRV and readiness scales. 5) Document materials and procedures.

Source: puretestedpeptides.com ↗

Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

Source: peptidemind.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →